A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS
3Citations signalées
14Institutions associées
1Pays d’affiliation
Résumé indisponible dans les métadonnées reçues.
Institutions
The University of Texas MD Anderson Cancer CenterDuke Cancer InstituteUniversity of Maryland, BaltimoreSidney Kimmel Comprehensive Cancer CenterUniversity of BaltimoreUniversity of Alabama at BirminghamMemorial Sloan Kettering Cancer CenterTexas OncologyOklahoma State University Oklahoma CityUniversity of Oklahoma Health Sciences CenterMoffitt Cancer CenterEmory HealthcareWinship Cancer InstituteYale Cancer Center
Sujets associés
Technology and Education SystemsCybersecurity and Cyber Warfare StudiesICT Impact and Policies